Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 512 results for "ranbaxy industries"

Ranbaxy whistle blower Dinesh Thakur suggests strict prosecuti...

NEW DELHI: Dinesh Thakur, the famous whistle blower who highlighted data manipulation issues at top Indian drug maker Ranbaxy (now part of Sun Pharma), says the country needs strict criminal prosecution against suppliers of substandard drugs, a ... Economic Times, 5 days ago
Bhupesh Bhandari: Listen to Dinesh Thakur Smart Investor, 1 month ago
Moneycontrol.com

Sun Pharma, Daiichi terminate transaction pacts

Daiichi Sankyo, Daiichi Sankyo (Thailand) Ltd, Sun Pharmaceutical Industries Ltd, Ranbaxy (Netherlands) BV and Ranbaxy (Thailand) Company Ltd entered into a termination agreement on May 26, 2016. Sun Pharmaceutical Industries today said the ...
 Moneycontrol.com1 month ago Daiichi Sankyo moves further to cut legacy Ranbaxy ties  FiercePharma1 month ago Sun Pharma shares surge over 4% on termination of transition pact with Daiichi  Financial Express1 month ago Sun Pharma shares surge over 5% on termination of transition pact with Daiichi  Financial Express1 month ago
[x]  

Not aware of adverse findings about manufacturing units of Ranbaxy: Sun Pharma

MUMBAI: Sun Pharmaceutical Industries said it isn't aware of any adverse findings related to the manufacturing plants of Ranbaxy Laboratories — which it acquired in 2014 — that are said to be part of an affidavit filed in the Supreme Court by ...
 Economic Times1 month ago

Assocham opens Madrid office

New Delhi, June 27 (IANS) Indian industry body Assocham on Monday opened an office in Madrid to deepen trade and investment relationship between India and Spain. The Associated Chambers of Commerce and Industry of India's Madrid office was opened ...
 Yahoo! India1 day ago
[x]  

Allowing 74% FDI in pharma sector may attract many MNCs to invest in India

The new Foreign Direct Investment (FDI) policy 2016 allowing 74 per cent FDI through automatic route in pharmaceutical industry will open up the foreign investments in pharma industry as many foreign companies are looking for an investment in ...
 PharmaBiz4 days ago Swadeshi andolan criticises India's FDI policy  Business Today India4 days ago Govt's pharma FDI sop may hit affordable healthcare  Financial Express5 days ago

Mylan says Indian drug industry needs more transparency from FDA

Rajiv Malik of Mylan's says the Indian pharmaceutical industry is working with the FDA to make the resolution of the regulatory issues more transparent Toronto: Mylan NV president Rajiv Malik said the Indian drug industry is starting to get ...
 Livemint.com5 days ago 'Frustrated'  Bloomberg5 days ago

Pharma M&As: value creator or value destroyer?

Anil Khanna , Partner, Tai Pi Advisors analyses the trend of rising M&As in the pharma industry and examines its causes and implications Anil Khanna What is it with M&As that they make the adrenalin skyrocket, or generate a strong urge to go ...
 Financial Express1 week ago

Six-month-old medical communication firm eMediNexus aims to on-board 4 lakh doctors in two years

It is a well-known fact that despite all the strides made in the healthcare industry in India, it is still afflicted by a majority of doctors lacking digital acceptance and awareness. Realising this, Nilesh Aggarwal, who had a six-year stint with ...
 Yourstory.in1 week ago
Livemint.com

Sun Pharma falls most in 10 months on March quarter results

Shares of Sun Pharmaceutical Industries closed 6.13% lower, posting their worst fall in 10 months, a day after the company posted lower-than-expected March quarter earnings Mumbai: Shares of Sun Pharmaceutical Industries Ltd closed 6.13% lower, ...
 Livemint.com4 weeks ago Sun Pharma shares drop 5.7% after results [Mint, New Delhi]  Bloomberg4 weeks ago
Afternoon Despatch & Courier

SUN PHARMACEUTICAL : Pharma launches cros in OTC segment, eyes 30% market share

Drug major Sun Pharmaceutical Industries today launched its sunscreen brand 'Suncros' through its Global Consumer Healthcare business vertical with a target of garnering 30 per cent market share in the next 2-3 years. Suncros was available only in ...
 4 Traders2 weeks ago Sun Pharma enters dermatology segment to expand OTC business  VC Circle2 weeks ago Sun Pharma launches Suncros in OTC segment, eyes 30% mkt share  Times of India2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less